Search company, investor...
MC10 company logo

MC10

mc10inc.com

Founded Year

2008

Stage

Convertible Note - III | Alive

Total Raised

$101.78M

Last Raised

$2.47M | 4 yrs ago

About MC10

MC10 provides a platform for biometric healthcare analytics. It offers digital solutions for improving human health. The company was founded in 2008 and is based in Lexington, Massachusetts.

Headquarters Location

10 Maguire Road Building 3, 1st Floor

Lexington, Massachusetts, 02421,

United States

(857) 214-5600

Missing: MC10's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: MC10's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing MC10

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

MC10 is included in 13 Expert Collections, including Wearable Computing.

W

Wearable Computing

424 items

Wearable computing is broadly defined as companies developing devices worn or placed on the body that are equipped with technology, which can range from wearable medical devices to AR/VR headsets to GPS pet collars.

C

Clinical Trials Tech

341 items

Companies developing products and services to streamline drug R&D, from drug discovery, pre-clinical testing, and clinical trials.

A

Advanced Materials

1,282 items

Startups developing new or improved materials (chemicals, alloys, etc.) that provide physical or functional advantages to basic materials.

A

Artificial Intelligence

10,393 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.

M

Medical Devices

11,963 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

D

Diabetes

1,904 items

MC10 Patents

MC10 has filed 110 patents.

The 3 most popular patent topics include:

  • Microcontrollers
  • Sensors
  • Computer memory
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/19/2017

10/26/2021

Mass spectrometry, Home automation, Ion source, Internet of things, Skin anatomy

Grant

Application Date

4/19/2017

Grant Date

10/26/2021

Title

Related Topics

Mass spectrometry, Home automation, Ion source, Internet of things, Skin anatomy

Status

Grant

Latest MC10 News

Wearable Pregnancy Devices Market will worth USD 10593.96 million by 2030 : GreyViews

Jan 6, 2023

Major Players OMRON Corporation, Medtronic PLC, Koninklijke Philips N.V., Fitbit Inc., Apple Inc., Bellabeat, 112Motion, Hitachi, Rubi Life LLC, MC10 Inc, BeWell Innovations, Biotricity Inc, Brainlab AG, Wave Hello, Nuvo Group among others. Segmentation Analysis Real-time contraction tracking devices are expected to be the fastest-growing segment in 2022. The product type segment includes real-time contraction tracking devices, health tracking devices, blood pressure monitoring devices and others. The portable vacuum therapy segment is expected to witness the highest growth rate during the forecast period. A real-time contraction tracking device keeps a record of your contractions, so you can gauge how quickly your labour is proceeding, so you can decide when to seek help. The trackers will also alert you when it's time to go to the hospital. All these factors are responsible for the huge demand for real-time contraction tracking devices which propels the growth of the market. Retail pharmacies are expected to be the fastest-growing segment in 2022. The distribution channel segment includes e-commerce, drug stores, retail pharmacies and hospital pharmacies. The retail pharmacies segment is expected to witness the highest growth rate during the forecast period. As the wearable pregnancy devices market continues to grow, the retail pharmacy segment has the largest share of sales, driven by the increasing number of complications related to pregnancy and the demand for the products among pregnant women. Regional Analysis            The regional analysis provides a detailed perception of the key regions and the countries. Some of the key countries analyzed for the wearable pregnancy devices market include the US, Canada, Mexico, Germany, France, the U.K., Italy, Spain, Russia, China, Japan, India, Brazil, Peru, UAE, South Africa, and Saudi Arabia. The North American region witnessed a major share. As a result of the rising adoption of new technology and increasing adoption of wearable technology, North American wearable pregnancy devices are expected to grow at a significant rate in the near future. Moreover, the market in the region should grow as a result of strategic initiatives taken by market players. Country Analysis Germany Germany's wearable pregnancy devices market size was valued at USD 182.26 million in 2022 and is expected to reach USD 844.60 million by 2030, at a CAGR of 20.8% from 2023 to 2030. Growing demand for wearable pregnancy devices is driving growth in the region due to an increase in the manufacturing and advancement of technology, as well as government funding of health initiatives during pregnancy. China China’s wearable pregnancy devices market size was valued at USD 189.5 million in 2022 and is expected to reach USD 870.74 million by 2030, at a CAGR of 21% from 2023 to 2030. It is expected that the wearable pregnancy device market will grow due to increasing adoption among early adopters, an improved healthcare infrastructure, an increasing disposable income, and an increased awareness of wearable pregnancy devices, which will drive market growth in the country. India India's wearable pregnancy devices market size was valued at USD 145.8 million in 2022 and is expected to reach USD 665.53 million by 2030, at a CAGR of 20.9% from 2023 to 2030. Technological advancements and modernization in the country will further enhance the market for wearable pregnancy devices during the forecast period. Rising government initiatives to spread awareness about the benefits of wearable pregnancy devices in order to reduce the risk of complications. Covid-19 Impact Covid-19 had a major impact on almost all industries, such as electronics, semiconductors, manufacturing, automobile, etc. However, several companies operating in the technology sector have seen increased revenue due to significant changes in consumer preferences toward technological services. In addition, the pandemic has led to significant growth in technology across developing and developed countries. Furthermore, the growth of this market is mainly driven owing to the increasing demand from the healthcare sector and rising complications during the pregnancy period, propelling the growth of the market across the countries. Buy Now Full Report @ https://greyviews.com/checkout/275/single_user_license Contact Us

MC10 Frequently Asked Questions (FAQ)

  • When was MC10 founded?

    MC10 was founded in 2008.

  • Where is MC10's headquarters?

    MC10's headquarters is located at 10 Maguire Road, Lexington.

  • What is MC10's latest funding round?

    MC10's latest funding round is Convertible Note - III.

  • How much did MC10 raise?

    MC10 raised a total of $101.78M.

  • Who are the investors of MC10?

    Investors of MC10 include North Bridge Venture Partners, Braemar Energy Ventures, Aberdare Ventures, LabCorp, Osage University Partners and 9 more.

  • Who are MC10's competitors?

    Competitors of MC10 include X-trodes.

Compare MC10 to Competitors

Onera Logo
Onera

Onera seeks to advance sleep medicine by creating diagnostic solutions and services, helping millions of people who struggle with sleep-related ailments, and ultimately improving the health and quality of life for patients.

X-trodes Logo
X-trodes

X-trodes is an Israeli bio-technology start-up developing unique wearable, wireless technology and advanced analytics of biopotential signals. Its core technology aims to be user-friendly, objective, automated and high-resolution and it is optimized for clinical evaluation and treatment. X-trodes has developed an ultra-soft, flexible and dry electrode array (Electro-Dot) system and machine learning (ML) driven algorithmic methodologies.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.